{
 "drug": "Flurazepam Hydrochloride Capsule",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "08/03/2022",
 "dayN": 1483,
 "cat": "Neurology",
 "companies": [
  "Chartwell Molecular Holdings LLC",
  "Rising Pharma Holdings, Inc."
 ],
 "reasons": [
  "Regulatory delay"
 ],
 "records": [
  {
   "update_type": "Reverified",
   "initial_posting_date": "08/03/2022",
   "package_ndc": "62135-737-30",
   "generic_name": "Flurazepam Hydrochloride Capsule",
   "contact_info": "845-268-5000 Ext. 510",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA072369"
    ],
    "brand_name": [
     "FLURAZEPAM HYDROCHLORIDE"
    ],
    "generic_name": [
     "FLURAZEPAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Chartwell RX, LLC"
    ],
    "product_ndc": [
     "62135-737",
     "62135-736"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "FLURAZEPAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "1298088",
     "1298091"
    ],
    "spl_id": [
     "25893c92-c8f1-567a-e063-6294a90a00d4"
    ],
    "spl_set_id": [
     "8f476891-1346-4e8c-ac1b-f8cbdc64f5a1"
    ],
    "package_ndc": [
     "62135-736-30",
     "62135-736-90",
     "62135-737-30",
     "62135-737-90"
    ],
    "unii": [
     "756RDM536M"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Neurology",
    "Other"
   ],
   "dosage_form": "Capsule",
   "presentation": "Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-30)",
   "company_name": "Chartwell Molecular Holdings LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "08/03/2022",
   "package_ndc": "62135-737-90",
   "generic_name": "Flurazepam Hydrochloride Capsule",
   "contact_info": "845-268-5000 Ext. 510",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA072369"
    ],
    "brand_name": [
     "FLURAZEPAM HYDROCHLORIDE"
    ],
    "generic_name": [
     "FLURAZEPAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Chartwell RX, LLC"
    ],
    "product_ndc": [
     "62135-737",
     "62135-736"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "FLURAZEPAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "1298088",
     "1298091"
    ],
    "spl_id": [
     "25893c92-c8f1-567a-e063-6294a90a00d4"
    ],
    "spl_set_id": [
     "8f476891-1346-4e8c-ac1b-f8cbdc64f5a1"
    ],
    "package_ndc": [
     "62135-736-30",
     "62135-736-90",
     "62135-737-30",
     "62135-737-90"
    ],
    "unii": [
     "756RDM536M"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Neurology",
    "Other"
   ],
   "dosage_form": "Capsule",
   "presentation": "Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90)",
   "company_name": "Chartwell Molecular Holdings LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "08/03/2022",
   "package_ndc": "62135-736-90",
   "generic_name": "Flurazepam Hydrochloride Capsule",
   "contact_info": "845-268-5000 Ext. 510",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA072368"
    ],
    "brand_name": [
     "FLURAZEPAM HYDROCHLORIDE"
    ],
    "generic_name": [
     "FLURAZEPAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Chartwell RX, LLC"
    ],
    "product_ndc": [
     "62135-736",
     "62135-737"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "FLURAZEPAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "1298088",
     "1298091"
    ],
    "spl_id": [
     "25893c92-c8f1-567a-e063-6294a90a00d4"
    ],
    "spl_set_id": [
     "8f476891-1346-4e8c-ac1b-f8cbdc64f5a1"
    ],
    "package_ndc": [
     "62135-736-30",
     "62135-736-90",
     "62135-737-30",
     "62135-737-90"
    ],
    "unii": [
     "756RDM536M"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Oncology",
    "Other"
   ],
   "dosage_form": "Capsule",
   "presentation": "Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-90)",
   "company_name": "Chartwell Molecular Holdings LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "08/03/2022",
   "package_ndc": "0378-4430-01",
   "generic_name": "Flurazepam Hydrochloride Capsule",
   "contact_info": "1-844-874-7464",
   "availability": "Unavailable",
   "related_info": "Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.",
   "update_date": "06/03/2026",
   "therapeutic_category": [
    "Neurology",
    "Other"
   ],
   "dosage_form": "Capsule",
   "presentation": "Flurazepam Hydrochloride, Capsule, 30 mg (NDC 0378-4430-01)",
   "company_name": "Rising Pharma Holdings, Inc.",
   "shortage_reason": "Regulatory delay",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "08/03/2022",
   "package_ndc": "0378-4415-01",
   "generic_name": "Flurazepam Hydrochloride Capsule",
   "contact_info": "1-844-874-7464",
   "availability": "Unavailable",
   "related_info": "Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.",
   "update_date": "06/03/2026",
   "therapeutic_category": [
    "Neurology",
    "Other"
   ],
   "dosage_form": "Capsule",
   "presentation": "Flurazepam Hydrochloride, Capsule, 15 mg (NDC 0378-4415-01)",
   "company_name": "Rising Pharma Holdings, Inc.",
   "shortage_reason": "Regulatory delay",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "08/03/2022",
   "package_ndc": "62135-736-30",
   "generic_name": "Flurazepam Hydrochloride Capsule",
   "contact_info": "845-268-5000 Ext. 510",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA072368"
    ],
    "brand_name": [
     "FLURAZEPAM HYDROCHLORIDE"
    ],
    "generic_name": [
     "FLURAZEPAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Chartwell RX, LLC"
    ],
    "product_ndc": [
     "62135-736",
     "62135-737"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "FLURAZEPAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "1298088",
     "1298091"
    ],
    "spl_id": [
     "25893c92-c8f1-567a-e063-6294a90a00d4"
    ],
    "spl_set_id": [
     "8f476891-1346-4e8c-ac1b-f8cbdc64f5a1"
    ],
    "package_ndc": [
     "62135-736-30",
     "62135-736-90",
     "62135-737-30",
     "62135-737-90"
    ],
    "unii": [
     "756RDM536M"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Neurology",
    "Other"
   ],
   "dosage_form": "Capsule",
   "presentation": "Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-30)",
   "company_name": "Chartwell Molecular Holdings LLC",
   "status": "Current"
  }
 ]
}